Published in BMJ on January 15, 1994
Risk factors for Salmonella Enteritidis and Typhimurium (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infections. Epidemiol Infect (2006) 1.57
Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections. Clin Microbiol Rev (2015) 1.48
Mortality study of 18 000 patients treated with omeprazole. Gut (2003) 1.39
Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study. BMJ (1996) 1.19
Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Eradication largely prevents relapse. BMJ (1994) 1.14
The effect of amoxycillin on salivary nitrite concentrations: an important mechanism of adverse reactions? Br J Clin Pharmacol (1995) 1.07
Insights into the future of gastric acid suppression. Nat Rev Gastroenterol Hepatol (2009) 0.98
Calcium in milk and fermentation by yoghurt bacteria increase the resistance of rats to Salmonella infection. Gut (1996) 0.93
Underestimation of Clostridium difficile infection among clinicians: an international survey. Eur J Clin Microbiol Infect Dis (2012) 0.88
Gastrointestinal problems in the immunosuppressed patient. Arch Dis Child (1998) 0.84
Pancreatic hyperamylasemia during acute gastroenteritis: incidence and clinical relevance. BMC Infect Dis (2001) 0.82
Inhibition of lysosomal enzyme activities by proton pump inhibitors. J Gastroenterol (2013) 0.82
Gastroenterology--I: Gastroduodenal disease and Helicobacter pylori. Postgrad Med J (1994) 0.77
Acute Transverse Myelitis Associated with Salmonella Bacteremia: A Case Report. Am J Case Rep (2016) 0.75
Risk factors for Salmonella infection. Risks higher in developing countries. BMJ (1994) 0.75
An unusual case of Salmonella Enteritidis causing pneumonia, septic shock and multiple organ failure in an immunocompetent patient. IDCases (2016) 0.75
Risk factors for Salmonella infection. Loss of gastric acid linked to candidiasis. BMJ (1994) 0.75
Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut (1972) 4.59
Relationship between gastric secretion and infection. Gut (1987) 2.09
Epidemiologic evidence that prior antimicrobial exposure decreases resistance to infection by antimicrobial-sensitive Salmonella. J Infect Dis (1990) 1.61
Severe salmonella infection in patients with reduced gastric acidity. Practitioner (1985) 1.25
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.89
Risk assessment after acute upper gastrointestinal haemorrhage. Gut (1996) 5.02
Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet (1996) 4.55
Policy alternatives for resource allocation. Lancet (1977) 4.52
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med (1998) 3.96
Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Br Med J (1974) 3.42
Enzyme amplified immunoassay: a novel technique applied to direct detection of Chlamydia trachomatis in clinical specimens. J Clin Pathol (1985) 3.33
Recommendations for standards of sedation and patient monitoring during gastrointestinal endoscopy. Gut (1991) 3.27
Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ (1992) 3.17
Sedation for upper gastrointestinal endoscopy: results of a nationwide survey. Gut (1991) 3.14
Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? Gastroenterology (1985) 3.12
Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79. Br Med J (Clin Res Ed) (1983) 2.91
Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy (2007) 2.88
14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet (1987) 2.68
Prevention of hypoxaemia during upper-gastrointestinal endoscopy by means of oxygen via nasal cannulae. Lancet (1987) 2.60
Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet (2001) 2.44
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med (1996) 2.37
Intravenous midazolam: a study of the degree of oxygen desaturation occurring during upper gastrointestinal endoscopy. Br J Clin Pharmacol (1987) 2.36
What is value for money in medical care? Experiences in England and Wales, Sweden, and the U. S. A. Lancet (1967) 2.36
Prevalence and "incidence" of celiac disease in Edinburgh and the Lothian region of Scotland. Gastroenterology (1986) 2.34
A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer (2000) 2.27
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet (1993) 2.20
Smoking and Crohn's disease. Br Med J (Clin Res Ed) (1984) 2.17
Hospital caseloads in Liverpool, New England, and Uppsala. An international comparison. Lancet (1968) 2.12
Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A (1997) 2.12
Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy. Lancet (1993) 2.10
Smoking and ulcerative colitis. Br Med J (Clin Res Ed) (1984) 2.05
Cigarette smoking and inflammatory bowel disease. Gastroenterology (1987) 2.04
Variation in outcome after acute upper gastrointestinal haemorrhage. The National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet (1995) 2.03
Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study. BMJ (2000) 2.02
Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut (1998) 2.02
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ (1992) 1.94
Prescribing in the UK. Lancet (2001) 1.93
Journals should see original protocols for clinical trials. BMJ (2001) 1.88
Enterotoxigenic Escherichia coli diarrhea of travelers: a prospective study of American Peace Corps volunteers. Johns Hopkins Med J (1977) 1.88
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
Reduction of gastrointestinal protein loss by elemental diet in Crohn's disease of the small bowel. Gut (1981) 1.77
Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders. Drugs (1998) 1.74
Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am J Physiol (1997) 1.70
Primary biliary cirrhosis and coeliac disease: an association? Lancet (1978) 1.70
Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J Clin Microbiol (1999) 1.69
Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut (2000) 1.69
Audit of mortality in upper gastrointestinal bleeding. Postgrad Med J (1989) 1.68
What predicts failed cannulation and therapy at ERCP? Results of a large-scale multicenter analysis. Endoscopy (2012) 1.68
Rapid assay of gentamicin. Lancet (1972) 1.64
Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial. Gut (2001) 1.63
Bacteriology and ultrastructure of the bladder in patients with urinary tract infections. J Infect (1985) 1.60
Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology (1997) 1.59
High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut (1991) 1.58
Carotinaemia. Br Med J (1942) 1.55
Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci (Lond) (1992) 1.53
Do preoperative chlorhexidine baths reduce the risk of infection after vascular reconstruction? Eur J Vasc Surg (1989) 1.52
Diabetes mellitus, anti-secretory drugs and other risk factors for campylobacter gastro-enteritis in adults: a case-control study. Epidemiol Infect (1997) 1.50
Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther (2010) 1.48
Paying for medical care. Need for debate. Lancet (1970) 1.48
Randomised observer blind comparative trial of ceftriaxone and penicillin in treating uncomplicated gonorrhoea in men and women. Genitourin Med (1986) 1.48
Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis. Endoscopy (2010) 1.44
A bacteriological survey of amputation wound sepsis. J Hosp Infect (1989) 1.43
Death in acute upper gastrointestinal bleeding. Can endoscopy reduce mortality? Lancet (1976) 1.43
Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta3. Am J Physiol (1999) 1.42
The Medical Check-up or Pre-symptomatic Diagnosis [Abridged]. Proc R Soc Med (1963) 1.40
Ileo-caecal ulceration associated with the use of diclofenac slow release. Aliment Pharmacol Ther (1993) 1.40
Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol Assess (2010) 1.40
Experience of 5-aminosalicylate nephrotoxicity in the United Kingdom. Aliment Pharmacol Ther (2005) 1.40
Monoclonal antigranulocyte antibody imaging in inflammatory bowel disease: a preliminary report. Nucl Med Commun (1992) 1.39
Mortality study of 18 000 patients treated with omeprazole. Gut (2003) 1.39
Somatostatin in treatment of haematemesis and melaena. Lancet (1985) 1.39
Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J Clin Microbiol (2000) 1.38
The Prader-Willi syndrome with a 15/15 translocation. Case report and review of the literature. J Med Genet (1976) 1.38
Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa. Gut (1983) 1.37
Prostaglandins and ulcerative colitis. Gut (1984) 1.36
Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Aliment Pharmacol Ther (2002) 1.35
An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol (2003) 1.34
Oesophageal cancer: a population-based study of survival after treatment. Br J Surg (1992) 1.33
Enteric fever and other extraintestinal salmonellosis in University Hospital, Nottingham, UK, between 1980 and 1997. Eur J Clin Microbiol Infect Dis (2000) 1.33
Screening for gastric cancer after gastric surgery. Lancet (1983) 1.32
Inhibition of prostaglandin synthetase in human rectal mucosa. Gut (1983) 1.32
Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther (2005) 1.32
Intravenous omeprazole rapidly raises intragastric pH. Gut (1985) 1.31
High definition colonoscopy vs. standard video endoscopy for the detection of colonic polyps: a meta-analysis. Endoscopy (2011) 1.30
Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut (1992) 1.30
5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut (2005) 1.29
Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme. Br J Cancer (2012) 1.29
Allelic diversity of the Helicobacter pylori vacuolating cytotoxin gene in South Africa: rarity of the vacA s1a genotype and natural occurrence of an s2/m1 allele. J Clin Microbiol (1999) 1.28
Sarcoidosis and coeliac disease: an association? Lancet (1984) 1.28
Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther (2005) 1.27
Audit of the investigation and outcome of iron-deficiency anaemia in one health district. J R Coll Physicians Lond (1996) 1.27
Synthesis of prostaglandin E2, thromboxane B2 and prostaglandin catabolism in gastritis and gastric ulcer. Gut (1986) 1.27
Acrosoxacin in the treatment of uncomplicated gonorrhoea. Br J Vener Dis (1983) 1.26
Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient. Br J Clin Pharmacol (1987) 1.26
Medical technology and the needs of chronic disease. A review of some British studies on the organization of medical care services. J Chronic Dis (1964) 1.25
Novel endoscopic observation in Barrett's oesophagus using high resolution magnification endoscopy and narrow band imaging. Aliment Pharmacol Ther (2007) 1.25
Breath hydrogen in pneumatosis cystoides intestinalis. Gut (1979) 1.24
Narrow-band imaging with magnification in Barrett's esophagus: validation of a simplified grading system of mucosal morphology patterns against histology. Endoscopy (2008) 1.24